Lucas Ward
Stock Analyst at Ascendiant Capital
(0)
# 5022
Out of 5,240 analysts
15
Total ratings
23.08%
Success rate
-39.90%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Aclarion | Maintains: Buy | 2 2 | 0.04 | 3150% | 3 | Nov 27, 2024 | |
LiqTech Intl | Maintains: Buy | 6 4 | 1.79 | 78.77% | 3 | Nov 25, 2024 | |
Vivos Therapeutics | Reiterates: Buy | 7 7 | 5 | 32% | 2 | Nov 20, 2024 | |
Heart Test Laborator... | Reiterates: Buy | 15 15 | 3.32 | 351.81% | 1 | Sep 23, 2024 | |
Cyclo Therapeutics | Maintains: Buy | 3 1 | 0.67 | 41.79% | 2 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 338 270 | 2.05 | 13070.73% | 2 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 29 | 0.91 | 3064.84% | 1 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 2160 | n/a | n/a | 1 | Mar 6, 2023 |